These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1793214)

  • 1. Immunopotentiation of anti-viral and anti-tumor immune responses using anti-T cell receptor antibodies and mitogens.
    Newell KA; Ellenhorn JD; Hirsch R; Bluestone JA
    Ann N Y Acad Sci; 1991 Dec; 636():279-87. PubMed ID: 1793214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
    Alegre ML; Peterson LJ; Xu D; Sattar HA; Jeyarajah DR; Kowalkowski K; Thistlethwaite JR; Zivin RA; Jolliffe L; Bluestone JA
    Transplantation; 1994 Jun; 57(11):1537-43. PubMed ID: 8009586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growth.
    Hirsch R; Ellenhorn JD; Bluestone JA
    Princess Takamatsu Symp; 1988; 19():237-43. PubMed ID: 2978618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
    Rothman BL; Blue ML; Kelley KA; Wunderlich D; Mierz DV; Aune TM
    J Immunol; 1991 Oct; 147(8):2493-9. PubMed ID: 1833455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Zivin RA; Collins A; Adair JR; Bodmer M; Athwal D; Alegre ML; Bluestone JA
    J Immunol; 1992 May; 148(9):2756-63. PubMed ID: 1533410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Fucello AJ; Stuart FP; Bluestone JA
    Transplantation; 1991 Aug; 52(2):361-8. PubMed ID: 1714644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions.
    Li B; Wang H; Dai J; Ji J; Qian W; Zhang D; Hou S; Guo Y
    Immunology; 2005 Dec; 116(4):487-98. PubMed ID: 16313362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pillars Article: OKT3: A Monoclonal Anti-Human T Lymphocyte Antibody with Potent Mitogenic Properties. J. Immunol. 1980. 124: 2708-2713.
    Van Wauwe JP; De Mey JR; Goossens JG
    J Immunol; 2016 Nov; 197(9):3431-3436. PubMed ID: 27824589
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
    Alegre ML; Collins AM; Pulito VL; Brosius RA; Olson WC; Zivin RA; Knowles R; Thistlethwaite JR; Jolliffe LK; Bluestone JA
    J Immunol; 1992 Jun; 148(11):3461-8. PubMed ID: 1534096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
    Cole MS; Anasetti C; Tso JY
    J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro.
    Parlevliet KJ; Chamuleau ME; Yong SL; Raasveld MH; ten Berge IJ; Schellekens PT
    Clin Exp Immunol; 1995 Feb; 99(2):155-9. PubMed ID: 7851005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T lymphocyte activation induced by monoclonal anti-CD3 antibodies: physiopathology of cytokine release].
    Chatenoud L; Bach JF
    C R Seances Soc Biol Fil; 1991; 185(5):268-77. PubMed ID: 1806186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells.
    Schwinzer R; Franklin RA; Domenico J; Renz H; Gelfand EW
    J Immunol; 1992 Mar; 148(5):1322-8. PubMed ID: 1371524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
    Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
    J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
    Bonnefoy-Berard N; Revillard JP
    J Heart Lung Transplant; 1996 May; 15(5):435-42. PubMed ID: 8771497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B.
    Alber G; Hammer DK; Fleischer B
    J Immunol; 1990 Jun; 144(12):4501-6. PubMed ID: 2161873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
    Ellenhorn JD; Schreiber H; Bluestone JA
    J Immunol; 1990 Apr; 144(7):2840-6. PubMed ID: 1969454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target cell-induced T cell activation with bi- and trispecific antibody fragments.
    Jung G; Freimann U; Von Marschall Z; Reisfeld RA; Wilmanns W
    Eur J Immunol; 1991 Oct; 21(10):2431-5. PubMed ID: 1655465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.